The forecasted decrease in private non-profit expenditure on R&D in medical and health sciences in Canada indicates a steady decline from 2024 to 2028, with values dropping from $66 million to $62 million. As we stand in 2024, these projections highlight an annual decrease of approximately 1.5% over the five-year span. This trend suggests a potential slowdown in investment by private non-profits in this sector, possibly due to economic constraints or shifting priorities. In 2023, the expenditure was at $67 million, showcasing a decrease in funding and highlighting a need for assessment of the sector's funding strategies.

Future trends to watch for include:

The impact of any new government policies or funding initiatives that could redirect non-profit investments.
Technological advancements that may necessitate increased R&D spending.
Changing health priorities post-pandemic, potentially altering investment focuses.